First Light Asset Management, LLC
Position in ELVN — Enliven Therapeutics, Inc.
CIK 1600004
EDINA, MN
Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,058,062
+$61,144,876 QoQ
Shares Held
1,360,750
+574.1% QoQ
Ownership
1.86%
of shares outstanding
% of Portfolio
4.20%
of 13F equity value
Holder Rank
#14
of 210 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Light Asset Management, LLC holds $573,690,960 across 11 Biotechnology names. ELVN ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
930,289 | $123,477,258 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
771,901 | $117,961,910 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
This page
|
1,360,750 | $69,058,062 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,360,866 | $50,923,605 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,095,171 | $44,496,797 | |
| 6 | ANAB |
Anaptysbio, Inc
|
582,004 | $39,285,270 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
|
2,097,215 | $39,113,059 | |
| 8 | SEPN |
Septerna, Inc.
|
963,260 | $32,259,577 |
All Filings in ELVN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,058,062 | 1,360,750 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,913,186 | 201,867 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||